Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Lorus Bringing Antisense Drug To Collaboration With Sumitomo

April 6, 2005

By Jennifer Boggs

Nuvelo's Secreted Protein Find Leads To Agreement With Kirin

April 5, 2005

By Jennifer Boggs

Nuvelo's Secreted Protein Find Leads To Agreement With Kirin

April 5, 2005

By Jennifer Boggs

Progenics Raising $30M For MNTX, HIV, Cancer Programs

April 4, 2005

By Jennifer Boggs

BioCurex licenses biomarker to Abbott in 1st major deal

April 4, 2005

By Jennifer Boggs

Progenics Raising $30M For MNTX, HIV, Cancer Programs

April 4, 2005

By Jennifer Boggs

ESBATech's Platform Subject Of Oncology Deal With Novartis

April 1, 2005

By Jennifer Boggs

ESBATech's Platform Subject Of Oncology Deal With Novartis

April 1, 2005

By Jennifer Boggs

Agennix Raises $22M Privately To Advance Lactoferrin Program

March 31, 2005

By Jennifer Boggs

Agennix Raises $22M Privately To Advance Lactoferrin Program

March 31, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...